| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |